Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Wenisch
C
C
Krause
R
R
Fladerer
P
P
El Menjawi
I
I
Pohanka
E
E
D000208:Acute Disease; D000368:Aged; D000800:Angioplasty, Balloon / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000628:therapy; D000069059:Atorvastatin; D004359:Drug Therapy, Combination; D005672:Fusidic Acid / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006949:Hyperlipidemias / Q000188:drug therapy; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000209:etiology; D016909:Tibial Arteries
D000900:Anti-Bacterial Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D005672:Fusidic Acid; D000069059:Atorvastatin